Competitive R Grants Insights (FY2024)
14,454 competitive NIH R-series awards in FY2024
Total Grants
14,454
FY 2,024–2,024Leading Mechanism
R01 · 51.31%
7,416 awardsFY2024 Volume
14,454
Competitive awards in FY2024Top Activity Codes
| Activity | Awards | Share |
|---|---|---|
| R01 | 7,416 | 51.31% |
| R21 | 1,913 | 13.24% |
| R35 | 1,365 | 9.44% |
| R03 | 430 | 2.97% |
| R44 | 414 | 2.86% |
| R13 | 406 | 2.81% |
| R43 | 401 | 2.77% |
| R15 | 289 | 2.00% |
| R56 | 275 | 1.90% |
| R25 | 251 | 1.74% |
Top Keyword Themes
Mice
×746
Mouse Models
×606
Mouse Model
×590
Humans
×552
Inflammation
×522
Proteomics
×498
Older Adults
×460
Randomized Controlled Trial
×456
Electrophysiology
×446
Neuroinflammation
×424
Feasibility
×418
Aging
×398
Competitive Anesthesia Portfolio (FY1985–FY2024)
3,501 anesthesia-linked competitive awards across FY1985–FY2024
Total Grants
3,501
FY 1,985–2,024Leading Mechanism
R01 · 64.50%
2,258 awardsFY2024 Volume
85
Competitive awards in FY2024Top Activity Codes
| Activity | Awards | Share |
|---|---|---|
| R01 | 2,258 | 64.50% |
| R21 | 282 | 8.05% |
| R43 | 214 | 6.11% |
| R03 | 137 | 3.91% |
| R44 | 120 | 3.43% |
| R29 | 99 | 2.83% |
| R35 | 54 | 1.54% |
| R15 | 47 | 1.34% |
| R13 | 39 | 1.11% |
| R41 | 34 | 0.97% |
Top Keyword Themes
Electrophysiology
×8
Immunohistochemistry
×8
In Vivo Imaging
×8
Mice
×8
Rats
×8
Anesthesia
×6
Chemogenetics
×6
Children
×6
Emergence Delirium
×6
General Anesthesia
×6
genetic variant study in Asians
×6
Hippocampus
×6
Massachusetts General Hospital Competitive Awards (FY1985–FY2024)
5,039 competitive MGH awards recorded between FY1985–FY2024
Total Grants
5,039
FY 1,985–2,024Leading Mechanism
R01 · 68.88%
3,471 awardsFY2024 Volume
195
Competitive awards in FY2024Top Activity Codes
| Activity | Awards | Share |
|---|---|---|
| R01 | 3,471 | 68.88% |
| R21 | 755 | 14.98% |
| R03 | 215 | 4.27% |
| R56 | 102 | 2.02% |
| R37 | 78 | 1.55% |
| R29 | 74 | 1.47% |
| R13 | 70 | 1.39% |
| RF1 | 41 | 0.81% |
| R25 | 38 | 0.75% |
| R35 | 35 | 0.69% |
Top Keyword Themes
Cost-Effectiveness
×16
Neuroinflammation
×14
Quality Of Life
×14
Cost-Effectiveness Analysis
×12
In Vivo Imaging
×12
Self-Efficacy
×12
Acceptability
×10
Alzheimer's Disease
×10
Emotional Distress
×10
Feasibility
×10
HIV infection
×10
Older Adults
×10